Why Smart Patients Choose EverydayMeds for 1.7mg Wegovy
1.7mg Wegovy Lowest Price UK — Transparent Value Without Compromise
At £139.99, our 1.7mg Wegovy represents the UK's most competitive pricing for this critical dose. Unlike other providers who add consultation fees, delivery charges, or membership costs, our price includes everything you need. This prescription-only medicine comes with comprehensive clinical assessment, qualified prescriber review, and temperature-controlled next-day delivery. You're investing in proven weight management support without the financial uncertainty that derails long-term success.
We understand that reaching weeks 13-16 represents significant commitment to your health journey. The 1.7mg dose marks the penultimate step before 2.4mg maintenance, where many patients experience accelerated results. Our pricing structure recognises this milestone — returning customers can apply code DOSE25 at checkout, ensuring your dedication is rewarded with sustained value. This isn't just about finding cheap Wegovy; it's about securing reliable, compliant access to your prescribed medication.
1.7mg Wegovy Pricing Breakdown — Bundle Savings and Strategic Planning
Beyond our competitive single-pen 1.7mg Wegovy price, we offer strategic bundles for forward-thinking patients. The Elevate Duo combines 1.7mg and 2.4mg for £369.99, providing seamless transition to maintenance dosing. For patients requiring extended 1.7mg stabilisation, our Consistency 1.7mg bundle delivers two pens for £309.99. Each bundle includes dual clinical assessments and maintains our commitment to comprehensive care without hidden extras.
Our Progressive Trio (0.5mg, 1mg, and 1.7mg) costs £369.99, perfect for patients stepping up gradually or managing side effects through controlled escalation. New customers benefit from code FIRST40 at checkout, while established patients use DOSE25 for continued savings. We're registered with the General Pharmaceutical Council (GPhC #9012878), ensuring every transaction meets UK regulatory standards while maintaining our lowest-price promise.
1.7mg Wegovy Clinical Evidence — STEP Trial Results for Informed Decisions
In clinical trials, patients taking Wegovy alongside diet and exercise achieved remarkable outcomes by the 1.7mg dose phase. The landmark STEP 1 trial demonstrated approximately 15% average weight loss at 68 weeks, with many participants showing significant progress during the 1.7mg period (Wilding et al., NEJM, 2021). The 1.7mg dose represents a crucial escalation point where appetite suppression typically intensifies.
STEP 3 trial results showed that patients combining Wegovy with intensive behavioural therapy achieved approximately clinically studied weight loss, with the 1.7mg phase marking accelerated progress for many participants. The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management. These results support continued investment in your 1.7mg Wegovy treatment at our competitive UK pricing.
How 1.7mg Wegovy Works — GLP-1 Receptor Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone at the 1.7mg therapeutic level. This prescription-only medicine works on brain appetite centres, significantly reducing hunger signals and promoting satiety after smaller meals. At 1.7mg, patients typically experience enhanced appetite control compared to lower doses, with food cravings often diminishing substantially. The once-weekly injection via FlexTouch pen ensures consistent therapeutic levels, maximising the appetite-suppressing effects throughout each seven-day period. This mechanism, combined with reduced-calorie diet and increased physical activity, creates the optimal environment for sustained weight management success.
1.7mg Wegovy Ordering Process — From Assessment to Delivery
Securing your 1.7mg Wegovy at the UK's lowest price takes just minutes through our streamlined process. Complete our comprehensive 3-minute online clinical assessment, designed specifically for weight management prescribing requirements under MHRA guidelines. Our qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring thorough evaluation while maintaining supply continuity. Once approved, your 1.7mg Wegovy ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. Our GPhC-registered pharmacy (#9012878) handles all dispensing, guaranteeing authentic Novo Nordisk medication direct to your door. Apply your discount code at checkout — FIRST40 for new customers, DOSE25 for returning patients.
1.7mg Wegovy Storage and Practical Considerations
Your 1.7mg Wegovy arrives in cold-chain packaging and must be refrigerated at 2-8°C before first use. Once removed from refrigeration, the FlexTouch pen remains stable for up to 6 weeks at room temperature below 30°C — significantly longer than Mounjaro's 21-day limit. This storage flexibility makes 1.7mg Wegovy ideal for travel and flexible lifestyle requirements during weeks 13-16 of treatment. Each pen contains four doses of 1.7mg semaglutide, administered once weekly via subcutaneous injection into thigh, abdomen, or upper arm. The dose escalation protocol requires completing the full 1.7mg phase before advancing to 2.4mg maintenance, ensuring optimal tolerance and efficacy. Never skip or accelerate doses without prescriber guidance.
1.7mg Wegovy Long-Term Investment Strategy — Cost-Effective Maintenance Planning
Reaching the 1.7mg dose represents substantial progress in your weight management journey, making cost optimisation crucial for long-term success. At £139.99, our 1.7mg Wegovy pricing enables sustainable treatment continuation without financial strain that often derails patient outcomes. Many patients use this phase to plan their maintenance strategy, with our Elevate Duo bundle providing smooth transition to 2.4mg dosing. The 1.7mg phase typically lasts four weeks, but some patients require extended stabilisation based on tolerance and response patterns.
Consider that STEP 1 extension trials showed patients regained approximately two-thirds of lost weight within one year of stopping treatment, making continued access at competitive pricing essential. Our returning customer discount (DOSE25) ensures your commitment to health doesn't become financially unsustainable. Smart patients often secure multiple months of supply during promotional periods, though proper storage and expiry date management remain crucial for medication efficacy.
Secure Your 1.7mg Wegovy Today — UK's Best competitive pricing
Don't let pricing uncertainty compromise your weight management success at this critical juncture. Our £139.99 rate for 1.7mg Wegovy represents the UK's most competitive offer, including comprehensive clinical assessment, prescriber review, and cold-chain delivery. New customers apply code FIRST40 at checkout, while returning patients use DOSE25 for continued savings. Express prescriber review ensures rapid supply continuity, crucial during dose escalation phases. Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to secure your supply today. Our GPhC-registered pharmacy (#9012878) ensures authentic Novo Nordisk medication with full regulatory compliance and professional support throughout your journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
